COR
Price
$291.61
Change
+$1.72 (+0.59%)
Updated
Aug 29 closing price
Capitalization
56.54B
68 days until earnings call
EDAP
Price
$2.26
Change
+$0.44 (+24.18%)
Updated
Aug 29 closing price
Capitalization
84.51M
74 days until earnings call
Interact to see
Advertisement

COR vs EDAP

Header iconCOR vs EDAP Comparison
Open Charts COR vs EDAPBanner chart's image
Cencora
Price$291.61
Change+$1.72 (+0.59%)
Volume$1.12M
Capitalization56.54B
EDAP TMS SA
Price$2.26
Change+$0.44 (+24.18%)
Volume$335.22K
Capitalization84.51M
COR vs EDAP Comparison Chart in %
Loading...
COR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EDAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COR vs. EDAP commentary
Aug 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COR is a Buy and EDAP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 31, 2025
Stock price -- (COR: $291.61 vs. EDAP: $2.26)
Brand notoriety: COR and EDAP are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: COR: 93% vs. EDAP: 374%
Market capitalization -- COR: $56.2B vs. EDAP: $84.51M
COR [@Medical Distributors] is valued at $56.2B. EDAP’s [@Medical Distributors] market capitalization is $84.51M. The market cap for tickers in the [@Medical Distributors] industry ranges from $85.41B to $0. The average market capitalization across the [@Medical Distributors] industry is $10.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COR’s FA Score shows that 3 FA rating(s) are green whileEDAP’s FA Score has 0 green FA rating(s).

  • COR’s FA Score: 3 green, 2 red.
  • EDAP’s FA Score: 0 green, 5 red.
According to our system of comparison, COR is a better buy in the long-term than EDAP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COR’s TA Score shows that 3 TA indicator(s) are bullish while EDAP’s TA Score has 5 bullish TA indicator(s).

  • COR’s TA Score: 3 bullish, 6 bearish.
  • EDAP’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, EDAP is a better buy in the short-term than COR.

Price Growth

COR (@Medical Distributors) experienced а -0.34% price change this week, while EDAP (@Medical Distributors) price change was +67.41% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +2.92%. For the same industry, the average monthly price growth was +3.59%, and the average quarterly price growth was -0.65%.

Reported Earning Dates

COR is expected to report earnings on Nov 06, 2025.

EDAP is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Medical Distributors (+2.92% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COR($56.5B) has a higher market cap than EDAP($84.5M). COR YTD gains are higher at: 30.576 vs. EDAP (2.262). COR has higher annual earnings (EBITDA): 4.02B vs. EDAP (-19.67M). COR has more cash in the bank: 2.23B vs. EDAP (22.8M). EDAP has less debt than COR: EDAP (9.08M) vs COR (8.24B). COR has higher revenues than EDAP: COR (317B) vs EDAP (62.8M).
COREDAPCOR / EDAP
Capitalization56.5B84.5M66,864%
EBITDA4.02B-19.67M-20,429%
Gain YTD30.5762.2621,351%
P/E Ratio29.94N/A-
Revenue317B62.8M504,777%
Total Cash2.23B22.8M9,789%
Total Debt8.24B9.08M90,769%
FUNDAMENTALS RATINGS
COR vs EDAP: Fundamental Ratings
COR
EDAP
OUTLOOK RATING
1..100
6230
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
99
Overvalued
PROFIT vs RISK RATING
1..100
2100
SMR RATING
1..100
1297
PRICE GROWTH RATING
1..100
5157
P/E GROWTH RATING
1..100
32100
SEASONALITY SCORE
1..100
6550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

COR's Valuation (75) in the Real Estate Investment Trusts industry is in the same range as EDAP (99) in the Biotechnology industry. This means that COR’s stock grew similarly to EDAP’s over the last 12 months.

COR's Profit vs Risk Rating (2) in the Real Estate Investment Trusts industry is significantly better than the same rating for EDAP (100) in the Biotechnology industry. This means that COR’s stock grew significantly faster than EDAP’s over the last 12 months.

COR's SMR Rating (12) in the Real Estate Investment Trusts industry is significantly better than the same rating for EDAP (97) in the Biotechnology industry. This means that COR’s stock grew significantly faster than EDAP’s over the last 12 months.

COR's Price Growth Rating (51) in the Real Estate Investment Trusts industry is in the same range as EDAP (57) in the Biotechnology industry. This means that COR’s stock grew similarly to EDAP’s over the last 12 months.

COR's P/E Growth Rating (32) in the Real Estate Investment Trusts industry is significantly better than the same rating for EDAP (100) in the Biotechnology industry. This means that COR’s stock grew significantly faster than EDAP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
COREDAP
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
67%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
48%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
46%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
41%
Bullish Trend 2 days ago
72%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 4 days ago
60%
Bullish Trend 2 days ago
74%
Declines
ODDS (%)
Bearish Trend 6 days ago
40%
Bearish Trend 10 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
39%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
COR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EDAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TTT76.071.52
+2.04%
ProShares UltraPro Short 20+ Year Trs
IQI9.420.05
+0.53%
INVESCO QUALITY Municipal SECURITIES
HYSD20.35-0.01
-0.07%
Columbia Short Duration High Yield ETF
SJNK25.54-0.03
-0.12%
SPDR® Blmbg ST HY Bd ETF
SPFF9.22-0.05
-0.53%
Global X SuperIncome™ Preferred ETF

COR and

Correlation & Price change

A.I.dvisor indicates that over the last year, COR has been loosely correlated with MCK. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if COR jumps, then MCK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COR
1D Price
Change %
COR100%
+0.59%
MCK - COR
66%
Loosely correlated
+0.83%
CAH - COR
51%
Loosely correlated
-0.49%
SHTDF - COR
17%
Poorly correlated
N/A
OMI - COR
13%
Poorly correlated
-1.21%
EDAP - COR
12%
Poorly correlated
+24.18%
More

EDAP and

Correlation & Price change

A.I.dvisor tells us that EDAP and AORT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EDAP and AORT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EDAP
1D Price
Change %
EDAP100%
+24.18%
AORT - EDAP
29%
Poorly correlated
+0.27%
AVNS - EDAP
21%
Poorly correlated
+0.59%
SRDX - EDAP
21%
Poorly correlated
-0.84%
UFPT - EDAP
20%
Poorly correlated
-0.53%
SENS - EDAP
20%
Poorly correlated
-0.11%
More